pubmed-article:8175308 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C0016911 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C0439855 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C2917410 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C1709630 | lld:lifeskim |
pubmed-article:8175308 | lifeskim:mentions | umls-concept:C1100336 | lld:lifeskim |
pubmed-article:8175308 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:8175308 | pubmed:dateCreated | 1994-6-8 | lld:pubmed |
pubmed-article:8175308 | pubmed:abstractText | Gadolinium III texaphyrin (Gd[III] texaphyrin) complex, a new magnetic resonance imaging contrast (MRI) agent, was evaluated. | lld:pubmed |
pubmed-article:8175308 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:language | eng | lld:pubmed |
pubmed-article:8175308 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8175308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8175308 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8175308 | pubmed:month | Mar | lld:pubmed |
pubmed-article:8175308 | pubmed:issn | 0020-9996 | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:YoungS WSW | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:MullerH HHH | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:QingFF | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:OnerCC | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:SidhuM KMK | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:MutchJ DJD | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:HemmiGG | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:NeuderMM | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:DouQQ | lld:pubmed |
pubmed-article:8175308 | pubmed:author | pubmed-author:ZanassiGG | lld:pubmed |
pubmed-article:8175308 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8175308 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:8175308 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8175308 | pubmed:authorsComplete | N | lld:pubmed |
pubmed-article:8175308 | pubmed:pagination | 330-8 | lld:pubmed |
pubmed-article:8175308 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:meshHeading | pubmed-meshheading:8175308-... | lld:pubmed |
pubmed-article:8175308 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:8175308 | pubmed:articleTitle | Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging. | lld:pubmed |
pubmed-article:8175308 | pubmed:affiliation | Department of Radiology, Stanford University School of Medicine. | lld:pubmed |
pubmed-article:8175308 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8175308 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8175308 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175308 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8175308 | lld:pubmed |